Cardiologists Hate Vytorin
Motley Fool
Tue, 09/2/08 - 06:37 pm
Big Pharma Pipeline: Why So Dry?
Seeking Alpha
Tue, 09/2/08 - 06:37 pm
Fresenius buyout of APP Pharmaceuticals expected to clear by mid-September
Yahoo/AP
Tue, 09/2/08 - 06:36 pm
No Vindication For Vytorin; Victory for Sciele
CNBC
Tue, 09/2/08 - 06:35 pm
Eli Lilly says experimental blood thinner beat Plavix at stopping heart attacks in diabetics
Yahoo/AP
Tue, 09/2/08 - 06:35 pm
Japanese Drug Industry Makes Another Billion-Dollar U.S. Buy
WSJ Online
Tue, 09/2/08 - 06:34 pm
Gilead may shoot past big firms' buyout hunts
San Francisco Chronicle, CA
Tue, 09/2/08 - 11:54 am
Sciele Pharma Shares Jump On Merger Deal
Trading Markets
Tue, 09/2/08 - 11:20 am
Alpharma adopts poison-pill plan to head off hostile takoever by King Pharmaceuticals
Yahoo/AP
Tue, 09/2/08 - 11:19 am
Introgen's Advexin Gets FDA Snub
The Street.com
Tue, 09/2/08 - 11:18 am
Study: No proof Vytorin linked to cancer; other doctors warn it should be used carefully
Yahoo/AP
Tue, 09/2/08 - 10:30 am
New England Journal of Medicine: Vytorin-Cancer Link ‘Uncertain’
WSJ Online
Tue, 09/2/08 - 10:27 am
Eli Lilly says olanzapine study shows treatment benefit for up to six months
Trading Markets
Tue, 09/2/08 - 10:24 am
Glaxo heart drug seen promising despite trial miss
Forbes
Tue, 09/2/08 - 10:23 am
Novo Nordisk says to boost U.S. marketing
Guardian, UK
Tue, 09/2/08 - 10:18 am
Three Biotech Stocks That Could Double
The Street.com
Tue, 09/2/08 - 10:17 am
GlaxoSmithKline scales back relationship with Adolor
Bizjournals.com
Tue, 09/2/08 - 10:12 am
Glaxo Drug Misses Main Study Goal, Still Has Promise
Bloomberg
Tue, 09/2/08 - 10:11 am
U.K.'s SkyePharma Drops Most in 16 Years on Share-Sale Plan
Bloomberg
Tue, 09/2/08 - 10:10 am
Sciele a Buy Since January
Zacks.com
Tue, 09/2/08 - 10:09 am

Pages